Invention Grant
- Patent Title: Cyclic peptides for the treatment of Graves' disease
-
Application No.: US16490358Application Date: 2018-02-28
-
Publication No.: US11459375B2Publication Date: 2022-10-04
- Inventor: Hans-Peter Holthoff , Martin Ungerer , Julia Fassbender , Zhongmin Li
- Applicant: advanceCOR GmbH
- Applicant Address: DE Martinsried
- Assignee: advanceCOR GmbH
- Current Assignee: advanceCOR GmbH
- Current Assignee Address: DE Martinsried
- Agency: Williams Mullen
- Agent David M. Saravitz
- Priority: EP17158652 20170301
- International Application: PCT/EP2018/054919 WO 20180228
- International Announcement: WO2018/158310 WO 20180907
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K14/72 ; A61P5/06 ; A61K38/00
Abstract:
The present invention relates to a cyclic peptide, its use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same.
Public/Granted literature
- US20200071384A1 CYCLIC PEPTIDES FOR THE TREATMENT OF GRAVES' DISEASE Public/Granted day:2020-03-05
Information query
